During the past decade, Louisiana Heart Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana Heart Hospital" #1 collaborator was "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana Heart Hospital" are "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Louisiana Heart Hospital" in a lesser frequency.

Most popular intervention types in "Louisiana Heart Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "COBRA PzF" (1 trials) and "pexelizumab in conjunction with CABG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Heart Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Louisiana Heart Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Louisiana Heart Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Heart Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".